Loading data
PCTNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 8.36 m USD | 0 USD | 0 USD | — | — |
| Research and development expense | 5.93 m USD | 6.48 m USD | 6.62 m USD | 4.35 m USD | 3.69 m USD |
| Selling, general and administrative expense | 59.48 m USD | 53.14 m USD | 55.26 m USD | 53.24 m USD | 57.62 m USD |
| Operating profit | -181.44 m USD | -145.38 m USD | -113.9 m USD | — | — |
| Interest expense | — | — | 31.37 m USD | 2.31 m USD | 7.47 m USD |
| Profit before tax | -181.6 m USD | -289.22 m USD | -101.07 m USD | -84.75 m USD | -77.5 m USD |
| Income tax expense | 970 k USD | -79 k USD | 650 k USD | 0 USD | 0 USD |
| Net income (reported basis) | -182.57 m USD | -289.14 m USD | -101.72 m USD | -84.75 m USD | -77.5 m USD |
| Net income attributable to common shareholders | -193.89 m USD | -289.14 m USD | -101.72 m USD | -84.75 m USD | -77.5 m USD |
| Basic earnings per share | -1.08 USD/share | -1.75 USD/share | -0.62 USD/share | -0.54 USD/share | -0.75 USD/share |
| Diluted earnings per share | -1.21 USD/share | -1.75 USD/share | -0.63 USD/share | -0.55 USD/share | -0.79 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.